Telix Pharmaceuticals Announces Us Fda Expanded Indication For Illuccix
By, Admin1 min read
Share
Telix Pharmaceuticals Announces That The United States Food And Drug Administration (Fda) Has Approved A Supplementary New Drug Application (Snda) For Illuccix
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
